Please sign in to follow a disease.
PSP - progressive supranuclear palsy
Clinical trials for PSP - progressive supranuclear palsy explained in plain language.
Never miss a new study
Get alerted when new PSP - progressive supranuclear palsy trials appear
Sign up with your email to follow new studies for PSP - progressive supranuclear palsy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a vaccine tame this rare brain disease?
Disease control By invitation onlyThis study tests a vaccine called AADvac1 in 146 people with progressive supranuclear palsy (PSP), a rare brain disorder that affects movement and thinking. The vaccine aims to target a protein linked to the disease and slow its progression. Participants will receive injections o…
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase 2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for PSP: experimental drug LM11A-31 enters key trial
Disease control By invitation onlyThis Phase 2 trial tests whether the drug LM11A-31 can slow the progression of Progressive Supranuclear Palsy (PSP), a rare brain disorder that affects movement and balance. About 147 people with early-stage PSP will receive either the drug or a placebo twice daily for several mo…
Matched conditions: PSP - PROGRESSIVE SUPRANUCLEAR PALSY
Phase 2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC